SG Americas Securities
LENZ

SG Americas Securities’s LENZ Therapeutics LENZ Stock Holding History

SG Americas Securities’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,458
Closed -$158K – 3813
2024
Q4 		$158K Buy
5,458
+935
+21% +$28.5K ﹤0.01% 2372
2024
Q3 		$107K Buy
+4,523
New +$100K ﹤0.01% 3016
2024
Q1 		– Sell
-2,190
Closed -$40K – 3519
2023
Q4 		$40K Buy
2,190
+430
+24% +$7.1K ﹤0.01% 2955
2023
Q3 		$31K Buy
+1,760
New +$30.6K ﹤0.01% 3012
2021
Q4 		– Sell
-1,035
Closed -$119K – 3867
2021
Q3 		$119K Buy
+1,035
New +$153K ﹤0.01% 3584

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return